• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Vaginal Delivery of Twin A and Cesarean Delivery for Twin B: Risk Factors and Outcomes

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Aviram et al. (AJOG, 2019) determined the incidence, risk factors, and outcomes for combined twin deliveries (Twin A: vaginal | Twin B: Cesarean)

METHODS:

  • Secondary analysis of a prospective, randomized, controlled trial
    • Data derived from the Twin Birth Study (TBS) RCT that compared planned vaginal delivery to planned combined delivery in twin pregnancies
  • Participants
    • Twin gestation
    • Between 32w0d and 38w6d
    • First twin vertex
  • Groups
    • Planned cesarean delivery
    • Planned vaginal delivery
  • Study design and data analysis
    • Comparison of women with combined vs vaginal delivery of both twins
  • Primary outcome
    • Risk factors for combined twin deliveries
  • Secondary outcomes
    • Rate of perinatal mortality and morbidity

RESULTS:

  • 842 women delivered twin A vaginally
    • Combined delivery: 7%
  • Women in the combined delivery group had
    • A lower rate of nulliparity (P = 0.047)
      • 22.0% vs 34.7%
    • Twin B: Higher rates of noncephalic presentation at delivery (P < 0.001)
      • 61.0% vs 27.3%
    • Twin B: Higher rates of spontaneous change in presentation from the time of randomization to the time of delivery (P < 0.0001)
      • 72.9% vs 44.3%
  • Transverse/oblique lie of twin B following delivery of twin A was associated with risk of combined delivery
    • Adjusted odds ratio (OR) 47.7 (95% CI, 15.4 to 124.5)
  • Comparing the combined delivery group to the group where both twins delivered vaginally, the frequency of adverse events in Twin B was significantly increased  
    • Fetal/neonatal death or serious neonatal morbidity
      • 13.6% vs 2.3% (P<0.001)
    • 5-minute Apgar score <7
      • 20.7% vs 2.1% (P<0.001)
    • NICU admission ≥48 hours
      • 12.07% vs 5.27% (P<0.001)
    • Abnormal level of consciousness (coma)
      • Coma 1.72% vs 0% (P =0.02)
    • Assisted ventilation ≥24 hours
      • 5.17% vs 0.90% (P<0.001)

CONCLUSION:

  • This study confirmed increased risk for combined delivery for twin B (e.g. mortality, morbidity, NICU admission, etc.)
  • The only risk factor for combined delivery following adjustment for confounding was transverse/oblique lie (not breech) of twin B following vaginal delivery of twin A
  • There was no association between adverse outcome in twin B and initial presentation of twin B or with inter-twin delivery interval
  • The authors suggest these results may have clinical implications including a discussion regarding “the policy of routine ‘double set-up’ for twin deliveries in the operating room, as a way to decrease the decision-to-incision interval”
  • Authors acknowledge limitations including the fact that the original TBS study was not powered for this study’s subanalysis

Learn More – Primary Sources:

The worst of both worlds—combined deliveries in twin gestations: a subanalysis of the Twin Birth Study, a randomized, controlled, prospective study

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Learn More  »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Planned Cesarean or Planned Vaginal Delivery for Twins?
Does Delayed Delivery of the Second Twin Improve Survival?
Trial of Labor After Cesarean for Twins and Risks for Adverse Outcomes

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site